Limited comparative data exist for the treatment of HIV-associated non-Hodgkin lymphoma.
We analyzed pooled individual patient data for 1546 patients from 19 prospective clinical …

Patients infected with human immunodeficiency virus (HIV) are at increased risk for
developing both non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL). Even if this …

Purpose The prognosis of HIV-infected patients with non-Hodgkin lymphoma in the highly
active antiretroviral therapy (HAART) era approaches that of the general population when …

Data addressing prognostication in patients with HIV related Burkitt lymphoma (HIV-BL)
currently treated remain scarce. We present an international analysis of 249 (United States …

Purpose To compare the prognostic factors for survival and the validity of the International
Prognostic Index (IPI) in patients with HIV-related diffuse large-cell lymphoma (HIV-DLCL) …

Simple Summary Non-Hodgkin lymphoma (NHL) is one of the most frequent HIV-related
neoplasms, and diffuse large B-cell lymphoma (DLBCL) is the most common subtype. In …

Objective: Since the introduction of combination antiretroviral therapy (cART) patients with
HIV-related diffuse large B-cell lymphoma (DLBCL) show better control of …

Non-Hodgkin lymphoma is the most common malignancy affecting people living with HIV
(PLWH). Among its several subtypes, diffuse large B-cell lymphoma (DLBCL) is an important …

Human immunodeficiency virus (HIV) infection is associated with an increased risk of
aggressive lymphoma, especially diffuse large B cell lymphoma (DLBCL). There are few …

Outcomes for diffuse large B‐cell lymphoma (DLBCL) in sub‐Saharan Africa (SSA) are
poorly described. We report mature data from one of the first prospective SSA cohorts …